Skip to main content
OpenTrials
Completed

NCT Number: NCT00000334

Comparison of Buprenorphine and Methadone - 3

The purpose of this study is to compare agonist and antagonist profile associated with buprenorphine vs. methadone during opiate withdrawal.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Opioid-related Disorders Chemically-Induced Disorders Mental Disorders Narcotic-Related Disorders Substance-Related Disorders

Age range

23 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 2

Primary location

Washington DC VA

Washington D.C., District of Columbia, 20422, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

buprenorphine

Drug

Primary outcomes

  1. Withdrawal severity

  2. Opiate agonist symptoms

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • Washington D.C. Veterans Affairs Medical Center

Registry information

Official study title

Pharmacological Comparison of Buprenorphine and Methadone

Important dates

Study start
2002
Primary completion
2004
Study completion
2005
First posted
Sep 21, 1999
Registry last updated
Jan 31, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.